Ekso Bionics Holdings Inc expected to post a loss of $1.14 a share - Earnings Preview

Ekso Bionics Holdings Inc EKSO is expected to show a rise in quarterly revenue when it reports results on October 27 (estimated) for the period ending September 30 2025

The San Rafael California California-based company is expected to report a 5.3% increase in revenue to $4.346 million from $4.13 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Ekso Bionics Holdings Inc is for a loss of $1.14 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $34.75, about 86% above its last closing price of $4.87